ZIM Laboratories Share Price History and Returns 2018 to 2024
ZIM Laboratories Limited | |||
 | Price: ₹108.77 | ||
| 52 Week Low: ₹89.50 52 Week High: ₹131.40 | |||
| Market Capital: 525.5 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: ZIM Laboratories Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: ZIM Laboratories Recent Performance
- 3: ZIM Laboratories Stock Price Chart From 2018 to 2024
- 4: ZIM Laboratories Stock Price History Table From 2018 to 2024
- 5: Analyzing the Impact of Investing in ZIM Laboratories
- 5.1: ZIM Laboratories Stock Returns In Last 5 Years
- 6: ZIM Laboratories Returns vs Bank FD Returns
ZIM Laboratories Stock Highlights
As of 20 Dec 2024, ZIM Laboratories Stock price is ₹108.77 which is ₹22.63 below 52-week high of ₹131.40 and ₹19.27 above 52-week low of ₹89.50
52-Week High Low
- ZIM Laboratories 52-Week High is ₹131.40 occurred on 24 Apr 2024
- ZIM Laboratories 52-Week Low is ₹89.50 occurred on 13 Mar 2024
All Time High
- The all-time high or the highest price that ZIM Laboratories stocks have ever touched was ₹152.70 and this occurred on 04 Aug 2023.
- The highest closing price at which ZIM Laboratories stocks have ever closed was ₹149.00 recorded on 03 Aug 2023.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
ZIM Laboratories Recent Performance
Over the past 15 trading days, the value of ZIM Laboratories's stock has decreased by ₹1.16 (-1.06%). On 28 Nov 2024, its one share was worth ₹109.93 and by 20 Dec 2024, the value dropped to ₹108.77. During this period it created a highest high of ₹127.98 and lowest low of ₹108.26.
Click on legend items to show/hide respective price lines
ZIM Laboratories Stock Price Chart From 2018 to 2024
Click on legend items to show/hide respective price lines
ZIM Laboratories Stock Price History Table From 2018 to 2024
| Year | ZIM Laboratories | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹108.77 | -5.8% | ↑ ₹127.00 ↓ ₹108.00 |
| 2023 | ₹115.35 | 18.6% | ↑ ₹152.00 ↓ ₹68.05 |
| 2022 | ₹97.20 | 146.5% | ↑ ₹129.00 ↓ ₹37.90 |
| 2021 | ₹39.42 | 31.2% | ↑ ₹63.15 ↓ ₹22.87 |
| 2020 | ₹30.03 | 27.6% | ↑ ₹43.82 ↓ ₹14.00 |
| 2019 | ₹23.52 | -51.6% | ↑ ₹58.17 ↓ ₹17.33 |
| 2018 | ₹48.57 | - | ↑ ₹80.80 ↓ ₹41.65 |
Analyzing the Impact of Investing in ZIM Laboratories
ZIM Laboratories Stock price in the year 2018 was ₹48.57. If you had invested ₹10,000 in ZIM Laboratories Stock in 2018, in 6 years, your investment would have grown to ₹22,394 by the end of 2024. This represents a positive return of 123% from 2018 to 2024, with a compound annual growth rate (CAGR) of 14.3%.
ZIM Laboratories Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹152.70 and lowest was: ₹14.00
- ZIM Laboratories Stock price in 2019 was ₹23.52
- By 2024, its stock price rose to ₹108.77
- It gave a positive return of over 362.5% with a CAGR of 35.8% over the last 5 years
- If you had invested ₹10,000 in ZIM Laboratories in 2019 then in 5 years, your investment would have grown to ₹46,245.74 by 2024, which is 4.62 times of your initial investment.
ZIM Laboratories Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| ZIM Laboratories Shares | ₹10,000 | ₹22,394.48 | 123.9% |
| Bank FD (Simple Interest) | ₹10,000 | ₹13,600 | 36.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹14,185.19 | 41.9% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
